Precision Medicine Collaboration and Licensing Deals 2019-2026

$4,995.00

Precision Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2026

Publication date
May 2026
Number of pages
700+
Product type
Research report
Report edition
8
SKU
CP2108

Request your free report sample

The definitive benchmark for precision medicine dealmaking

Precision medicine partnering is driven by the integration of data, diagnostics, and targeted therapies, with deal structures reflecting patient stratification strategies and increasingly personalised approaches to treatment.

This report provides a comprehensive and structured analysis of 1350+ precision medicine collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.


Establish a clear view of market standards

The report enables a precise understanding of how precision medicine deals are structured in practice, allowing you to:

  • Benchmark comparable transactions with confidence
    Detailed analysis of upfronts, milestones, and royalty structures across relevant deals

  • Define realistic market parameters
    Clear insight into how deal terms vary by technology type, therapeutic alignment, and partner profile

  • Support valuation and structuring decisions with evidence
    Ground internal discussions in real transaction data rather than assumptions

  • Understand how leading companies approach dealmaking
    Visibility into partner behaviour and recurring deal structures across a data-driven and highly integrated therapeutic landscape


Full visibility into deal structure and execution

Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

  • Rights granted and retained

  • Development and commercialization responsibilities

  • Financial structures and payment triggers

  • Key contractual provisions and protections

This level of transparency is critical to understanding how value, risk, and control are allocated within precision medicine partnerships, particularly where coordination across diagnostics, therapeutics, and data platforms is required.


Designed for real-world BD and strategy use

The report is widely used to:

  • Structure and benchmark precision medicine transactions

  • Prepare for negotiations with well-defined market context

  • Evaluate cross-functional partnerships and counterparties

  • Support internal strategy with robust, defensible data


What’s included

  • 1350+ precision medicine collaboration and licensing deals

  • Financial terms, including upfronts, milestones, and royalties where disclosed

  • Fully searchable deal directory (by company, technology, and therapeutic alignment)

  • Direct access to SEC-filed agreements and source documents

  • Analysis of deal trends, key transactions, and active dealmakers


A trusted, evidence-based reference for precision medicine dealmaking

Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how precision medicine partnerships are structured, negotiated, and valued.

Precision Medicine Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2019
•    Browse precision medicine collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in precision medicine dealmaking
2.1. Introduction
2.2. Precision medicine deals over the years
2.3. Most active precision medicine dealmakers
2.4. Precision medicine deals by deal type
2.5. Precision medicine deals by therapy area
2.6. Precision medicine deals by industry sector
2.7. Deal terms for precision medicine deals
2.7.1 Precision medicine deals headline values
2.7.2 Precision medicine deal upfront payments
2.7.3 Precision medicine deal milestone payments
2.7.4 Precision medicine royalty rates

Chapter 3 – Leading precision medicine deals
3.1. Introduction
3.2. Top precision medicine deals by value

Chapter 4 – Most active precision medicine dealmakers
4.1. Introduction
4.2. Most active precision medicine dealmakers
4.3. Most active precision medicine deals company profiles

Chapter 5 – Precision medicine contracts dealmaking directory
5.1. Introduction
5.2. Precision medicine contracts dealmaking directory

Chapter 6 – Precision medicine dealmaking by technology type

Deal directory

Deal directory – Precision medicine deals by company A-Z
Deal directory – Precision medicine deals by deal type
Deal directory – Precision medicine deals by therapy area

Deal type definitions

About Biopharma Research Ltd 
Current Partnering
Current Agreements
Recent report titles from Current Partnering



Table of figures

Figure 1: Precision medicine deals since 2019
Figure 2: Active precision medicine dealmaking activity
Figure 3: Precision medicine deals by deal type since 2019
Figure 4: Precision medicine deals by therapy area since 2019
Figure 5: Precision medicine deals by industry sector since 2019
Figure 6: Precision medicine deals with a headline value
Figure 7: Precision medicine deals with an upfront value
Figure 8: Precision medicine deals with a milestone value
Figure 9: Precision medicine deals with a royalty rate value
Figure 10: Top precision medicine deals by value since 2019
Figure 11: Most active precision medicine dealmakers
Figure 12: Precision medicine deals by technology type since 2019

Pricing options

  • $4,995: single-user (encrypted file - one user/device)
  • $6,995: multi-user (encrypted file - up to 5 users/devices)
  • $8,995: company (unencrypted PDF)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

2bPrecise, 2cureX, 2seventy bio, 4baseCare, 4bases, 4D Molecular Therapeutics, 4D Path, 10X Genomics, 22nd Century, 23andMe, A*STAR Singapore Immunology Network, A2 Biotherapeutics, Abbisko Therapeutics, Abbott Laboratories, Abbvie, Abcam, AbCellera Biologics, AbFero Pharmaceuticals, ABL Bio, ABL Diagnostics, ABX-CRO Advanced Pharmaceutical Services, Accelerated Biosciences, Accelerate Technologies, AccessDx Laboratory, Access to Comprehensive Genomic Profiling Coalition, AccuGenomics, AccuStem Sciences, Acerta Pharma, Achilles Therapeutics, Aclipse Therapeutics, Acrivon Therapeutics, Acrobat Genomics, Active Motif, Adaptive Biotechnologies, ADC Therapeutics, Addario Lung Cancer Medical Institute, Adial Pharmaceuticals, Adiso Therapeutics, Adlai Nortye, Adrestia, Adva Biotechnology, Advanced Biological Laboratories, AdventHealth, ADx NeuroSciences, AESOP Technology, Agathos Biologics, AgBiome, AGC Biologics, Age Labs, Agena Bioscience, Agendia, Agilent Technologies, Agios Pharmaceuticals, Agriplex Genomics, AHN Autoimmunity Institute, Aignostics, AIkido Pharma, AiLife Diagnostics, AimedBio, Akadeum Life Sciences, Akoya Biosciences, Alamar Biosciences, Alberta Health Services, Albert Einstein College of Medicine, Alcedis, Alchemab, Alector, Alkyon Therapeutics, All4Cure, Allarity Therapeutics, Allegheny General Hospital, Alligator Bioscience, Alloy Therapeutics, Allscripts, Allumiqs, Almac Group, Almaden Genomics, Alnylam Pharmaceuticals, Alphageneron Pharmaceuticals, Alto Neuroscience, Alyatec, Alzheimer's Drug Discovery Foundation, ALZpath, Amazon Web Services, Ambry Genetics, American Lung Association, American Skin Association, Amerimmune, Amgen, Amoy Diagnostics, AMRA Medical, Amydis, Analytical BioSciences, AnchorDx, Angers University, AnHeart Therapeutics, Anivive Lifesciences, Ankyra Therapeutics, Apollomics, Applied Biosystems, Applied Cells, Applied DNA Sciences, APST Research, Aptorum Group, Arbor Biosciences, Arbor Biotechnologies, ArcherDX, ARCHIMEDlife, Arcis Biotechnology, Arcturus Therapeutics, Arcus Biosciences, Arena Pharmaceuticals, Ares Genetics, Ariadne Genomics, Ariana Pharma, AriBio, Ariel Precision Medicine, Arima Genomics, Arizona State University, AroCell, Artios Pharma, Arvinas, Asa Ren, Ashvattha Therapeutics, Aslan Pharma, Assistance Publique-Hôpitaux de Paris, Associazione Poic e Dintorni APS, Asthma UK, AstraZeneca, Asuragen, ATAI Life Sciences, Atara Biotherapeutics, Atlas Antibodies, AtlasXomics, Augurex Life Sciences, AUM Biosciences, Aural Analytics, Australian Genome Research Facility, Australian Research Data Commons, Autonomous Therapeutics, Avacta, Avance Biosciences, Avatamed, Avera Health, Avidity Biosciences, AXIM Biotechnologies, AyoxxA Biosystems, Babraham Institute, Banyan Biomarkers, Basepair, Basepaws, Battelle, Baxter International, Bayer, Bayer CropScience, Baylor College of Medicine, Baylor Genetics, Baylor Scott and White Research Institute, BC Cancer Agency, BC Platforms, Beacon Biosignals, Beckman Coulter, Becton Dickinson, BeiGene, Beijing Genomics Institute (BGI), Beijing Xisike Clinical Oncology Research Foundation, BenevolentAI, Berg, Berry Genomics, Beth Israel Deaconess Medical Center, BGI Americas, Big Eye Diagnostics, BigOmics Analytics, Bill and Melinda Gates Foundation, Bio-Medical Science, Bio-Rad Laboratories, Bio-Techne, BioAge Labs, Biocartis, Biocept, BioCheetah, Biocodices, Biodesix, Biofidelity, Biogen, Biogenar, Biogenysis, Biognosys, BioIntelliSense, BioLegend, BioLizard, BioLum Sciences, BioMap, BioMarin Pharmaceutical, Biomarker Collaborative, BioMarker Strategies, Biomedical Advanced Research and Development Authority, Biomedix, bioMerieux, BiomX, Bionomics, BioNTech, BioReference Laboratories, Biosearch Technologies, BioSkryb, Biosplice, BioVectra, Bird Foundation, bitBiome, Blu Biotech, Bluebee, Blueprint Genetics, Blueprint Medicines, BlueRock Therapeutics, Boca Biolistics, Boehringer Ingelheim, BostonGene, BPGbio, Bpifrance, BRAINBox Solutions, Brain Trauma Foundation, Breakthrough Genomics, Breath Diagnostics, Brenus Pharma, BriaCell Therapeutics, Bridge Biotherapeutics, BridGene Biosciences, Brigham and Women's Hospital, Bristol-Myers Squibb, Broad Clinical Labs, Broad Institute, Brown University, Buhler, Burning Rock, Busan Paik Hospital, C2i Genomics, C4X Discovery, Calviri, Calyxt, Cambridge Cancer Genomics, Cambridge Quantum Computing, CAMP4 Therapeutics, Canadian Council, Canary Speech, Cancer Research Horizons, Canopy Biosciences, Cantabio Pharmaceuticals, Caraway Therapeutics, CareDx, Caribou Biosciences, Carina Biotech, Caring Cross, Caris Life Sciences, Cartana, CarThera, CARTI Cancer Center, Cartography Biosciences, CASI Pharmaceuticals, Catholic University Leuven, CBD Solutions, Cedars-Sinai Medical Center, Celemics, Celgene, Cell and Gene Therapy Catapult, Cellaria Biosciences, CellChorus, Cellgen Diagnostics, Cellipont Bioservices, Cellkey, Cell Mogrify, Cellworks, Celmatix, Celsius Therapeutics, Centene, Center for Aquaculture Technologies, Center for Biomarker Research in Medicine, Center for Forensic Science Research & Education, Centers for Disease Control and Prevention, Centogene, Centre for Clinical Cancer Research, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Research in Agricultural Genomics, Cepheid, Cerba Research, Cerveau Technologies, Chan Zuckerberg Initiative, Chao Center, Charcot-Marie-Tooth Association, Charite Universitatsmedizin Berlin, Chembio Diagnostics, Children's Hospital Boston, Children's Hospital of Philadelphia, Children’s Center for Cancer and Blood Diseases (CCCBD), Chinese Academy of Agricultural Science, Chinook Therapeutics, ChromaCode, Chroma Medicine, Chugai Pharmaceutical, CHU Sainte-Justine, Cicero Diagnostics, Cipherome, Circle Pharma, Circuit Clinical, Circular Genomics, City of Hope, CK Life Sciences, Clene Nanomedicine, Cleveland Clinic, Clexio, Closed Loop Medicine, Clover Therapeutics, CMT Research Foundation, CND Life Sciences, Coastar Therapeutics, Codexis, Cofactor Genomics, Cogia Biotech, Cognition Therapeutics, CogState, Cohen Veterans Bioscience, Colorado Center for Personalized Medicine, Columbia University, Columbia University Medical Center, Complete Genomics, ConcertAI, Concert Genetics, Concr, Congenica, CoreBiome, Coriell Life Sciences, Cornell University, Corteva Agriscience, CosmosID, COTA, Crohn's and Colitis Foundation of America, Crown Bioscience, Cryostem, CStone Pharmaceuticals, Culmination Bio, CureMatch, CureScience, Curetis, CureVac, Curio Genomics, Curis, CvergenX, Cyclerion Therapeutics, Cyclica, CYduct Diagnostics, Cystic Fibrosis Foundation, CYTOVIA Therapeutics, Daiichi Sankyo, Dana-Farber Cancer Institute, Danaher, Danish Cancer Society Research Center, Dante Genomics, Dante Labs, DaRui Biotech, DarwinHealth, DataRobot, Data Tecnica International, Day One Biopharmaceuticals, Deargen, Debiopharm, Decipher Biosciences, Decode Health, Deep Genomics, Deep Longevity, Delfi Diagnostics, Denali Therapeutics, Dendreon, Denovo Biopharma, Department of Health - Abu Dhabi, Devyser Diagnostics, DHR Health, Diaceutics, DiamiR, Diamyd Medical, Diatech Pharmacogenetics, Discovery Life Sciences, Divergence Neuro Technologies, Diversigen, DNAnexus, DNA Script, DoMore Diagnostics, Dovetail Genomics, DrChrono, Duchenne UK, Duke-NUS Graduate Medical School Singapore, Duke University, Duke University Health System, DuPont, DuPont Pioneer, DxVx, Eccrine Systems, Editas Medicine, Eisai, Element Biosciences, Elevation Oncology, Eli Lilly, Elo Life Systems, Elsevier, Elysium Health, EMD Serono, Emedgene, Emendo Biotherapeutics, EncrypGen, Endocanna Health, ENDRA Life Sciences, Enigma Biomedical, ENPICOM, Ensoma, Entheon Biomedical, Epic, Epic Sciences, Epicypher, EpiVax Therapeutics, Erasmus University Medical Center, ERS Genomics, ErVimmune, ESYA Labs, Ethos Research & Development, Eucure Biopharma, Euformatics, Eureka Eurostars, Eurobio Scientific, Eurofins Scientific, European Union, Evaxion Biotech, Evofem Biosciences, Evogen, EvolveImmune Therapeutics, Evotec, Evvy, Exact Sciences, Exagen Diagnostics, Exosome Sciences, Exscientia, Fabric Genomics, Factorial Biotechnologies, Factorial Diagnostics, Falco, FDNA, Fibrogen, Fight Colorectal Cancer, FinnGen, Firefly Neuroscience, First Genetics JCS, FivepHusion, Flagship Biosciences, Flare Therapeutics, Flatiron Health, Flow Pharma, Fluent BioSciences, Fluidigm, FMC, Food Allergy Research & Education, Food and Drug Administration (FDA), Forian, Fortis Life Sciences, Fortis Therapeutics, Foundation for Innovative New Diagnostics, Foundation for the National Institutes of Health (FNIH), Foundation Medicine, Fox Chase Cancer Center, FOXO Technologies, Fred Hutchinson Cancer Research Center, Freenome, Friends of Cancer Research, Front Range Biosciences, FSHD Global Research Foundation, Fujirebio Diagnostics, Fujitsu Laboratories, Fulgent Genetics, Fulgent Pharma, Fundacion Progreso y Salud, Fusion Genomics, Fusion Pharmaceuticals, FYR Diagnostics, G+FLAS Life Sciences, G1 Therapeutics, G42 Healthcare, Gabriella Miller Kids First Data Resource Center, Galapagos, Galatea Bio, Galmed Pharmaceuticals, Ganymede Bio, GATC Health, Gate Neurosciences, Gateway for Cancer Research, GC Cell, GC Genome, GEDmatch, GE Healthcare, Geisel School of Medicine at Dartmouth, Gemini Therapeutics, Gencove, Gene by Gene, GeneCentric Therapeutics, Genective, GeneDX, GeneMatters, GenEmbryomics, Genentech, Geneoscopy, General Genomics, General Inception, Geneseeq, Genetica, Genetic Alliance, Genetika+, Genetiks, Genetron Health, Geneyx, Genialis, Geninus, Genolution, Genome Canada, Genome Diagnostics, Genome Insight, Genome Medical, Genomenon, Genomes2People, Genomic Biopharma, Genomics England, Genomic Testing Cooperative, Genomind, Genomoncology, GenoScreen, Genosity, Gensaic, GenScript Biotech, Genspace, Genuity Science, GenXys, Genzeva, Georgetown University, German Cancer Research Center, German Federal Ministry of Education and Research, Gibson Oncology, GI Innovation, Gilead Sciences, Ginkgo BioWorks, Global Cancer Technology, Glympse Bio, Gnosis Bioresearch, GNS Healthcare, Goldfinch Bio, Google, Government of South Korea, Grail, Greenlight Biosciences, Gretel, Gritstone Bio, GSK, Guardant Health, Gusto Global, H3 Biomedicine, Hackensack Meridian Health, Hadassah Medical Center, Halia Therapeutics, HalioDx, Hamilton Company, Hamilton Robotics, Hanmi Pharmaceutical, Hannover Medical School, HaploX, Harvard Medical School, Harvard University, HAYA Therapeutics, Healix, Hebrew University of Jerusalem, Heligenics, Helix, Helomics, Henan Cancer Hospital, Hengenix Biotech, Hengrui Therapeutics, Henlius Biotech, Henry Ford Health System, Henry M. Jackson Foundation, HepaTx, Hepion Pharmaceuticals, Hereditary Neuropathy Foundation, HiberCell, Hitachi, Hitachi High-Technologies Corporation, HMNC Brain Health, Hoag Memorial Hospital Presbyterian, Horizon Discovery, Horizon Europe, Hospital for Sick Children, HotSpot Therapeutics, HP, HTG Molecular Diagnostics, Hudson-Alpha Institute for Biotechnology, Human Cell Atlas, Hummingbird Bioscience, Hummingbird Diagnostics, Hurdle, I-mab, IBM, IBM Watson Health, Icahn School of Medicine at Mount Sinai, Icometrix, IDbyDNA, IDEAYA Biosciences, Idorsia, Igentify, Ikena Oncology, Illumina, Image Analysis, Imagene Labs, ImaginAb, Imaware, IMBdx, Imec, Imeka, Immodulon Therapeutics, Immunai, ImmunoAdoptive Cell Therapy, Immunovia, IMPACT Therapeutics, Imperial College London, Imugene, IncellDx, Incyte, Indiana University, Indica Labs, Indivumed, IndyGeneUS AI, InfYnity Biomarkers, Inivata, INmune Bio, InnoBation, Innodem Neurosciences, Innoplexus, Innosuisse, Innovate UK, Inocras, Inotrem, Inovio Pharmaceuticals, Inserm, InsightRX, Insitro, InSphero, Institut Curie, Institute for Systems Biology, Institut Gustave Roussy, Integra, Integra Biosciences, Integrated Biosciences, Integrated DNA Technologies, Intel, Intellia Therapeutics, Intelligence Advanced Research Projects Activity (IARPA), Intelliseq, Intermountain Healthcare, Intermountain Precision Genomics, International Center for Genetic Engineering and Biotechnology, International Centers for Precision Oncology Foundation, International Rice Research Institute, InterVenn, Invectys, Inventiva, inviCRO, Invitae, InVivoScribe, Ionis Pharmaceuticals, iPrime Therapeutics, iProgen Biotech, iReceptor Plus, Isogenica, IsoPlexis, Israeli National Authority for Technological Innovation, iThera Medical, ITM Isotopen Technologien, IV BioHoldings, Ix Therapeutics, Jackson Laboratory, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, JASE Health, Jazz Pharmaceuticals, Jefferson Healthcare, Jeffrey Modell Foundation, JelloX Biotech, Jenga Biosciences, Johns Hopkins University, Johnson & Johnson Innovation, JSR Life Sciences, Jubilant Therapeutics, Jumpcode Genomics, Juvenile Diabetes Research Foundation, Juventas Therapeutics, JW Biotechnology, K2bio, Kahn-Sagol-Maccabi, Kanazawa University, Kartos Therapeutics, Karyopharm Therapeutics, Kayagene, Keen Eye, Keio Gijuku University, Keygene, KeyWise, Khalpey AI Lab, Kineta, King Abdullah International Research Center, Kings College London, Kiyatec, Komodo Health, Konica Minolta Precision Medicine, Koye Pharmaceuticals, KPMG, Kronos Bio, Kura Oncology, Kymera Therapeutics, Kytopen, Kyverna Therapeutics, L'Oreal, Laboratorio Curie, Laboratory Corporation of America, La Jolla Institute for Allergy & Immunology, Lantern Pharma, Lantheus Holding, Latvian Institute of Organic Synthesis, Lawson Health Research Institute, Leap Therapeutics, Lee Moffitt Cancer Center, Lehigh Valley Health Network, Leibniz-Institut fur Molekulare Pharmakologie, Leica Biosystems, Lenovo, Lesaffre, Les Laboratoires Servier, Lexent Bio, LEXEO Therapeutics, Lexogen, LGC, LifeLabs Medical Laboratory Services, LifeMap Sciences, LifeOmic, Life Raft Group, Li Ka Shing Foundation, Linus Biotechnology, Lipidomics Consulting, Liquid Biosciences, LMU University Hospital Munich, Locus Biosciences, LogicBio Therapeutics, Longenesis, Lonza, Loxo Oncology, Lukas Biomedical, Lunaphore, Lung Cancer Research Foundation, Lunit, Lupus Research Alliance, M42, Maccabi Healthcare Services, Macrogen, Mainz Biomed, Mannin Research, MapKure, Massachusetts General Hospital, Massachusetts Institute of Technology, Mass General Brigham, Massive Bio, Mater Research, Maxim Integrated, Maxim Ventures, Mayo Clinic, MBio Diagnostics, MC10, McKesson, McMaster University, MD Anderson Cancer Center, MD Biosciences, Medgenics, MedGenome, MEDIAN Technologies, Medical College of Georgia, Medical College of Wisconsin, Medical Research Council, Medical University of Graz, Medical University of Vienna, Medicinal Genomics, Medicines Discovery Catapult, MEDiC Life Sciences, Medicover, Medis Medical Imaging, Medivizor, Meharry Medical College, Meiogenix, Mekonos, Memorial Sloan Kettering Cancer Center, Menarini Silicon Biosystems, Merck and Co, Merck KGaA, Merus, Mesh Bio, Metabolon, Metis Therapeutics, MGI Pharma, MGI Tech, Michael J Fox Foundation, Michelson Center, Microba Life Sciences, MicroGenDX, MicroMGx, Micronoma, Microsoft, MiLaboratories, Miltenyi Biotec, Mind Medicine, MiNK Therapeutics, Mirada Medical, Mirador Therapeutics, Mirati Therapeutics, miRecule, Mirnax Biosens, Miroculus, Mirus Bio, Mission Bio, Mission Cure, Mitsubishi Tanabe Pharma, MOBILion Systems, Moderna, Molecular Health, Moleculera Labs, Montreal Heart Institute, MorphoSys, Moss Genomics, MP Group, mProbe Laboratories, Multimmune, MultiOmic Health, Multiple Myeloma Research Foundation, Multiplex Genomics, Multiply Labs, Muscular Dystrophy Association, MyBiotics Pharma, My Care Express Merrillville, myDNA, MYND Life Sciences, myNEO, My Personal Therapeutics, Myriad Genetics, Myrtelle, n-Lorem Foundation, NABsys, Nalagenetics, Namocell, Nanite, Nankai Hospital, NanoCellect Biomedica, NanoMab Technology, Nanostics Precision Health, NanoString Technologies, NanoView Biosciences, Nashville Biosciences, NATA, Natera, National Cancer Center, National Cancer Center of Japan, National Cancer Centre Singapore, National Cancer Institute, National Comprehensive Cancer Network (NCCN), National Health Service, National Human Genome Research Institute, National Institute for Health Research (NIHR), National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal Diseases, National Institute of Child Health and Human Development, National Institute of General Medical Sciences, National Institute on Aging, National Institutes of Health, Naval Medical Research Center, Navamedic, Navidea Biopharmaceuticals, Navigate BioPharma Services, Navigo Proteins, Navinci Diagnostics, Nebraska Medicine, Nebula Genomics, NEC, NEC Bio Therapeutics, Nektar Therapeutics, Neo7Bioscience, Neochromosome, NeoDynamics, Neogap Therapeutics, Neogen, Neogenomics, Nepean Blue Mountains Local Health District’s Nepean Hospital, NeraCare, NervGen Pharma, NetraMark, Neumora Therapeutics, NeuraLight, Neuraly, NeuroGenesis, NeuroLex Laboratories, NeuroMetrix, Neuron23, NeuroSense Therapeutics, New England Biolabs, New Horizon Health, Newomics, NewStem, New York Blood Center, New York University School of Medicine, Nexilico, Next Gen Diagnostics, Next Generation Manufacturing Canada, NGeneBio, Nico, Nilogen Oncosystems, NIMML Institute, NImmune Biopharma, Nippon Kayaku, Nitto Avecia, NMI Natural and Medical Sciences Institute, Nona Biosciences, Nonacus, Normunity, Northern RNA, North Med, Northwest Biotherapeutics, Notable Labs, NovAccess Global, Novartis, Novigenix, Novogene, Novo Nordisk, Nrgene, Nucleai, Nucleix, Numares, NuProbe, Nurosene, Nvidia, NYU Grossman School of Medicine for Preclinical and Clinical Research, Ocean Genomics, Ochre Bio, Octant, Odimma Therapeutics, Offspring Biosciences, Ohio State University, Oklahoma Medical Research Foundation, Olaris, Olink Bioscience, Olink Proteomics, OMAPiX, Omico, OmniaBio, Omniome, OMNY Health, Oncoceutics, OncoCyte, Oncodesign, OncoDNA, Oncoheroes Biosciences, OncoHost, OncoImmunity, Oncologie, Oncology Venture, Oncompass Medicine, Onconova Therapeutics, Oncora Medical, Oncoshot, OncXerna Therapeutics, One Biosciences, One Codex, OneOncology, OneThree Biotech, ONK Therapeutics, Ono Pharmaceutical, Ontada, Ontario Institute for Cancer Research, OpenBench, Opentrons Labworks, Optellum, Optina Diagnostics, OracleBio, Orchid Cellmark, Ordaos Bio, Oregon Health Sciences University, Oregon Therapeutics, OrigiMed, Origin Agritech, Orion, Oryzon, OSE Immunotherapeutics, Oslo University Hospital, Oswaldo Cruz Foundation (Fiocruz), Ovation, Owkin, Owlstone Medical, Oxford Biodynamics, Oxford Nanopore Technologies, Ozette Technologies, Pacific Biosciences, Paige, Palisade Bio, Pancreatic Cancer Action Network, Pancreatic Cancer Collective, Pancreatic Cancer Early Detection Consortium, Pangea Biomed, Paragon Genomics, Parent Project Muscular Dystrophy, Parexel, Parse Biosciences, Partner Therapeutics, PathAI, Path BioAnalytics, PathGroup, Patia, Paul Scherrer Institute, Pearsanta, PEAR Therapeutics, Pennsylvania State University, Pepscan, PerkinElmer, Persephone Biosciences, Personal Genome Diagnostics, Personalis, Perthera, PetaGene, Pfizer, Phanes Therapeutics, Pharmanovia, Pharus Diagnostics, Phase Genomics, Phenomix, Physiomics, PhysIQ, Pierian, PierianDx, Pierre Fabre, Pillar Biosciences, Pioneer Hi-Bred, Pionyr Immunotherapeutics, PlaqueTec, PlumCare, Pluristem Therapeutics, Pluristyx, Plus Therapeutics, PMV Pharma, PreciseDx, Precision Diabetes, Precision for Medicine, Precision Genetics, Precision Health Informatics, PrecisionLife, Precision NanoSystems, Predicine, Predictive Oncology, Prelude Therapeutics, Premier Inc, PreMIT, Prenetics, Prenosis, Prepaire Labs, Prescient Medical, Princess Margaret Hospital, Progenesis, Progentec Diagnostics, PrognomIQ, Prognos, Project 8p Foundation, Prolytix, Promega, Prometheus Biosciences, ProPath, Prophase Labs, Proscia, Prostate Cancer Clinical Trials Consortium, Protean BioDiagnostics, Proteic Bioscience, ProteoMediX, Proteona, Protxx, Provista Diagnostics, Pryzm Health, Psomagen, Pulmonary Fibrosis Foundation (PFF), Q-State Biosciences, Q2 Solutions, Qatar Foundation, QIAGEN, Quanterix, Quantinm, Quantum Leap Health Care Collaborative, Queen Mary University of London, Quest Diagnostics, Quotient, QurAlis, R-Pharm, rAAVen Therapeutics, Race Oncology, Radius Health, Rady Children's Institute for Genomic Medicine, RareCyte, RayBiotech, Readout Health, Realm IDx, Recombia Biosciences, Redx Pharma, RefleXion Medical, Regeneron Genetics Center, Regeneron Pharmaceuticals, Regulus Therapeutics, Related Sciences, Relay Therapeutics, RenalytixAI, Renato Dulbecco Foundation, Renji Hospital, Rensselaer Polytechnic Institute, Repare Therapeutics, Repertoire Genesis, Replicate Bioscience, Research Council of Norway, Resilient Biotics, Resolution Bioscience, Resolve Biosciences, Reveal Genomics, Revitalist Lifestyle and Wellness, Revive Therapeutics, RevolKa, Revolution Medicines, Revvity, Rheos Medicines, Rice University, Ricoh, RIKEN Center for Integrative Medical Sciences, RIKEN Research Institute, Ripe Technology, Roche, Roche Diagnostics, Rockefeller University, Rockley Photonics, Roivant Sciences, Roswell Biotechnologies, Roswell Park Cancer Institute, Royal College of Surgeons (Ireland), Royal Philips Electronics, Rush University Medical Center, Rutgers Cancer Institute of New Jersey, Rutgers University, RxGenomix, Ryailti, Rymedi, S2 Genomics, Saga University, SalioGen Therapeutics, Sana Biotechnology, Sanford Health, Sangamo Therapeutics, Sanofi, Sano Genetics, Saol Therapeutics, Saphetor, Sarah Cannon Research Institute, Sarepta Therapeutics, Scailyte, Scale Biosciences, Scandion Oncology, Scarab Genomics, Schrodinger, Scienta Lab, Scipher Medicine, Scorpion Therapeutics, Secarna Pharmaceuticals, Second Genome, Sema4, Seneca Therapeutics, Sengenics, SEngine Precision Medicine, Sensyne Health, Sentieon, Sentinel Diagnostics, Seoul National University, Seqster, Sequentify, SeQure Dx, SeqWell, Serokell, Serosep, Serotiny, Seven Bridges Genomics, Sheffield Institute for Translational Neuroscience, Shenzhen Chipscreen Biosciences, Shepherd Therapeutics, Shimadzu, Shionogi, Shire Human Genetic Therapies, Shuttle Pharmaceuticals, Shuwen Biotech, Siemens Healthineers, SimBioSys, Simsen Diagnostics, Singapore Eye Research Institute (SERI), Singleron Biotechnologies, Singular Genomics Systems, Siolta Therapeutics, Sirona Dx, SkylineDX, Skysong Innovations, Sohm, SomaLogic, Sonde Health, Sonrai Analytics, Sookmyung Women's University, SOPHiA Genetics, Soricimed Biopharma, Sorrento Therapeutics, Sosei Heptares, Spanios, Spanish National Cancer Research Centre, Spark Biomedical, Spatial Genomics, Spectrum Solutions, SpeeDx, Spesana, Sphingotec, Spruce Biosciences, SPT Labtech, SQI Diagnostics, SquareOne Wellness, SRI International, St. Jude Children's Research Hospital, Stalicla, Stallargenes, Stallergenes Greer, Standard BioTools, Stanford University, Stanford University School of Medicine, Stella Diagnostics, Stem Genomics, Stem Pharm, Steno Diabetes Center, Step Pharma, St Luke's University Health Network of Bethlehem, Stockholm University, Strand Life Sciences, Strata Oncology, STRATIFYER Molecular Pathology, Streck Laboratories, Structural Genomics Consortium, Sumitomo Dainippon Pharma, Sumitovant Biopharma, Summit Pharmaceuticals, Sunnybrook Research Institute, Sun Pharma Advanced Research Company, Susan G. Komen for the Cure, Swift Biosciences, Swiss Institute of Bioinformatics (SIB), Syapse, Syncromune, Syndax Pharmaceuticals, SynGAP Research Fund, Synthego, Sysmex, Sysmex Inostics, T-Cure Bioscience, T-NeuroDx, Tabula Rasa HealthCare, Tagomics, Taiwan Precision Medicine Initiative, Takara Bio, Takeda Pharmaceutical, Takeda Ventures, Tampa General Hospital Cancer Institute, Tampere University Hospital, Tasly Pharmaceuticals, Tavros Therapeutics, Taysha Gene Therapies, Tecan, Telix Pharmaceuticals, Tempus, Tennessee Oncology, TeraRecon, Terran Biosciences, Tesis Biosciences, Tessera Therapeutics, Texas Oncology, TGen Drug Development, The Cure Parkinson's Trust, The New York Stem Cell Foundation, The Parker Institute For Cancer Immunotherapy, Theralink Technologies, Theraly Fibrosis, TheraPanacea, Thermo Fisher Scientific, The Silverstein Foundation for Parkinson's, Thomas Jefferson University, Todos Medical, Tokyo Medical and Dental University, TONIX Pharmaceuticals, Tor Vergata University Hospital, Total Brain, Traaser, Trajan Scientific and Medical, Trakcel, Transcenta, Transgene, Translational Drug Development, Translational Genomics Research Institute, Translational Software, Transnetyx, Transomic Technologies, Travera, Trialbee, TruGenomix, TScan Therapeutics, TwinStrand Biosciences, Twinstrand Therapeutics, Twist Bioscience, Tymora Analytical Operations, UCB, Ultima Genomics, Ultivue, Umoja Biopharma, Univeristy of Durham, University College London, University Health Network, University Hospital Heidelberg, University Hospitals Case Medical Center, University of Alabama at Birmingham, University of Alberta, University of Arkansas, University of Bern, University of Bonn, University of Buffalo, University of California, San Diego, University of California Berkeley, University of California Irvine, University of California Los Angeles, University of California San Francisco, University of California Santa Cruz, University of Chicago, University of Colorado, University of Colorado Denver, University of Florida, University of Glasgow, University of Heidelberg, University of Hong Kong, University of Houston, University of Illinois, University of Illinois Urbana-Champaign, University of Lausanne, University of Leeds, University of Ljubljana, University of Manchester, University of Maryland, University of Maryland Baltimore, University of Massachusetts, University of Miami, University of Michigan, University of Minnesota, University of Nebraska, University of Newcastle, University of New South Wales, University of Ottowa, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Rochester, University of Rochester Medical Center, University of Sheffield, University of Sydney, University of Texas, University of Texas Health Science Center at Houston, University of Tokyo, University of Toronto, University of Tubingen, University of Verona, University of Washington, University of Wisconsin, University of Wisconsin Carbone Cancer Center (UWCCC), University of Wollongong, US Oncology, Vaccinex, Valence Discovery, Vall d’Hebron Research Institute, Valo Health, Vanderbilt University, Varian Medical Systems, Variant Bio, Vector Laboratories, Veracyte, Veravas, Veraxa Biotech, Verge Genomics, Verily, VeriSIM Life, Veritas, Verogen, Versea Ophthalmics, Vertex Pharmaceuticals, VGI Health Technology, VIB, Vibrent Health, Victoria University, VieCure, ViewMind, Viewpoint Molecular Targeting, ViewRay, Viome, Vir Biotechnology, Virginia Commonwealth University, Visiopharm, Vivante Health, Vizgen, Vocalis Health, Volta Labs, Voltron Therapeutics, Voronoi, Vyant Bio, Wasatch BioLabs, Washington University in St Louis, Watchmaker Genomics, WAVE Life Sciences, Weihai Weigao Medical Devices, Weill Cornell Medical College, Wellcome Trust Sanger Institute, Wellmarker Bio, Western Digital, Whitehead Institute, WIN Consortium, WinterLight Labs, Wuxi STA, Xcell Biosciences, xCures, Xencor, Xpress Technologies, XtalPi, Yale Cancer Center, Yale School of Medicine, Yale University, Yeda Research and Development Company, Yissum Research Development, Ymir Genomics, ZAI Laboratory, ZERO Childhood Cancer, ZS Pharma, Zymergen, Zymo Research

About Current Partnering

A definitive, evidence-based approach to dealmaking intelligence

Current Partnering is the industry-leading provider of pharmaceutical and biotech dealmaking intelligence, delivering a clear, structured, and evidence-based view of how partnerships are designed, negotiated, and executed in practice.

Our reports combine comprehensive deal coverage, structured data analysis, and contract-level insight, enabling a deeper understanding of how financial terms, rights, and responsibilities are defined across real-world transactions.

All reports are updated every six months, ensuring users have access to the latest deal activity, trends, and market developments.


Our methodology

Built on a continuously updated proprietary database

All analysis is underpinned by Current Agreements, our proprietary deals and alliances database which is updated daily by our analysts as new transactions are announced globally.

Deal records are continuously reviewed and enriched as additional information becomes available, ensuring accuracy, completeness, and relevance.


Comprehensive and verifiable data sourcing

Deal data is sourced from publicly available industry disclosures, including:

  • Company press releases and announcements
  • SEC filings and equivalent regulatory disclosures
  • Company and investor presentations
  • Conference materials and company websites

All sources are captured and referenced, enabling full transparency and user verification.


Broad coverage across deal types and structures

Current Partnering provides comprehensive coverage across a wide range of deal types, including but not limited to:

  • Licensing and co-development
  • Research and collaborative R&D
  • Manufacturing, supply, and distribution
  • Commercialisation and co-promotion
  • Equity investments, joint ventures, and asset transactions
  • Options, royalties, and financing agreements

This breadth ensures a complete view of how partnerships are structured across the life sciences sector.


Structured, standardised analysis

Every deal is analysed using a consistent framework, capturing (where disclosed):

  • Financial terms — including upfront payments, milestones, and royalties
  • Rights allocation — development, manufacturing, and commercialization responsibilities
  • Deal structure — exclusivity, territorial scope, and agreement type
  • Contractual provisions — clauses defining risk, control, and value-sharing

Each deal record is fully categorised, including data fields such as:

  • Therapy area and technology type
  • Stage of development
  • Asset type and deal components
  • Geographic scope and exclusivity
  • Source documentation, including press releases and SEC filings

Financial normalisation for comparability

All financial values are standardised to USD using the exchange rate at the time of deal announcement, enabling consistent comparison of deal terms across geographies.


Contract-level insight

Where available, reports include direct access to underlying agreement documents, providing visibility into how deals are constructed in practice.

This enables users to understand:

  • How financial mechanisms are defined and triggered
  • How responsibilities are operationalised between parties
  • How flexibility, risk, and control are allocated within agreements

Designed for real-world application

Current Partnering reports are built to support business-critical decision-making across the life sciences ecosystem, including:

  • Pharmaceutical and biotech companies — benchmarking deals, structuring transactions, and supporting licensing strategy
  • Investment firms and venture capital — assessing deal benchmarks, valuation expectations, and partner behaviour
  • Advisory, legal, and consulting firms — supporting client engagements with real-world precedent and contract-level insight

Common use cases include:

  • Benchmarking comparable transactions
  • Supporting valuation and deal structuring
  • Preparing for negotiations
  • Evaluating potential partners
  • Informing internal strategy with real-world evidence

A trusted industry reference

With a long track record in the sector, Current Partnering is relied upon by leading pharmaceutical companies, emerging biotechs, investors, and advisory firms as a trusted source of dealmaking intelligence.

By combining proprietary data, rigorous methodology, and contract-level insight, our reports provide a reliable and authoritative foundation for understanding how deals are structured, negotiated, and valued.